Magazine article Drug Topics

New Products

Magazine article Drug Topics

New Products

Article excerpt

Rx Care

New Drag

Covidien launches TussiCaps Extended Releaee Capsules (hydrocodone polistirex/chloipheniramine polistjrex). TussiCaps, for cough suppression, is the only extended-release capsule formula that contains hydrocodone and chlorpheniramine, providing powerful cough suppression for up to 12 hours. According to the manufacturer, this new product, which contains a consistent dose of the medication, offers more precise and convenient dosing than liquid furin illations. For more information visit www.covidlen.com or call 441-2982480.

Coria Laboratories Ltd. has launched Tetrix Cream [1] for the management of various dermatoses. Tetrix Cream is a nonsterile cream formulation that has dem- onstrated its effectiveness in clinical trials as a barrier to irritants and allergens such as nickel sulfate, neomy- cin, a mixture of fragrances, and/or lactic acid. Tetrix Cream offers dermatologists a new modality with which to manage the burning and itching associated with vari- ous commonly seen derma- toses, such as chronic hand dermatitis. The cream is designated as a 51OK device by the U.S. Food and Drug Administration (FDA). For more information, visit www.tetrixcream.com or call (866) 819-9007.

DizzyFIX has been approved for sale in the United States by FDA. Made in Canada by Clearwater, DizzyFIX is an at-home treatment for vertigo and dizziness that helps guide patients through the Epley maneuver. According to its manufacturer, DizzyFIX will now be available by prescription in the United States. A low-cost patent-pending dy- namic visual-feedback device that easily attaches to a hat, DizzyFIX is geared to patients with benign paroxysmal positional vertigo (BPPV), one of the leading causes of dizziness, which affects as many as 10 percent of people older than 60. To learn more about DizzyFIX, visit DizzyFIX.com or call (877) 349-9934.

Sanofi-Aventis announced that the FDA has approved Nasacort AQ Nasal Spray (triamcinolone acetonide) for children ages 2 to 5 for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis. Contact Sanofi-Aventis at (908) 981-6563.

OTC

Prestige Brands Holdings Inc. announces the launch of Chloraseptic Allergen Block and Little Allergies Allergen Block [2]. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.